Order or find a test

The National Genomic Test Directories specify which genomic tests are commissioned by the NHS in England, to be delivered by Genomic Laboratory Hubs.

Clinical Indication ID & Name

M3

Breast Cancer

Test Group

Solid Tumours (Adult)

Specialties

Test code

M3.2

Test name

Multi-target expression array (Oncotype DX)

Target genes

Multiple - as per proprietary NICE-approved assay

Test scope

Other - Gene Expression

Test method/ technology

Other

Optimal Family Structure

n/a

Eligibility Criteria

As per NICE recommendations in ER positive, HER2 negative, lymph node negative early breast cancer

Test code

M3.3

Test name

Multi-target expression array (Endopredict)

Target genes

Multiple - as per proprietary NICE-approved assay

Test scope

Other - Gene Expression

Test method/ technology

Other

Optimal Family Structure

n/a

Eligibility Criteria

As per NICE recommendations in ER positive, HER2 negative, lymph node negative early breast cancer

Test code

M3.4

Test name

Multi-target expression array (Prosignia)

Target genes

Multiple - as per proprietary NICE-approved assay

Test scope

Other - Gene Expression

Test method/ technology

Other

Optimal Family Structure

n/a

Eligibility Criteria

As per NICE recommendations in ER positive, HER2 negative, lymph node negative early breast cancer

Test code

M3.5

Test name

Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3)

Target genes

NTRK1, NTRK2, NTRK3

Test scope

Structural variant detection

Test method/ technology

Panel

Optimal Family Structure

n/a

Eligibility Criteria

Patient’s clinical status means they are eligible for an NTRK inhibitor in the event an NTRK rearrangement is detected

Test code

M3.6

Test name

Multi-target NGS panel - small variant (PIK3CA)

Target genes

PIK3CA

Test scope

Small variant detection

Test method/ technology

Panel

Optimal Family Structure

n/a

Eligibility Criteria

Molecular assessment will aid diagnosis or management

Test code

M3.7

Test name

DPYD hotspot

Target genes

DPYD

Test scope

Small variant detection

Test method/ technology

Simple targeted mutation testing

Optimal Family Structure

n/a

Eligibility Criteria

Patient planned to receive fluoropyrimidine treatment

Test code

M3.9

Test name

ETV6-NTRK3 FISH/RT-PCR

Target genes

ETV6-NTRK3

Test scope

Structural variant detection

Test method/ technology

FISH/Simple targeted mutation testing

Optimal Family Structure

n/a

Eligibility Criteria

To support testing for suspected secretory carcinoma of the breast. Specialist pathology review indicates that molecular assessment will aid diagnosis or management.

Commissioning group

n/a

Overlapping idications

n/a

Address for samples/request forms

Cancer Genetics
Genetics Laboratories
5th Floor Tower Wing
Guy’s Hospital
Great Maze Pond
London
SE1 9RT

Contact with queries

gst-tr.gtabsoutheastglh@nhs.net

Supporting documents

n/a

Education resources

n/a

Turn around times

All our turnaround times are listed on our specific turn around page https://southeastgenomics.nhs.uk/professionals/service-turn-around-times/

Consent record

See consent guidance in test request form

Sample requirements

Samples may be rejected for the following reasons: 1.Samples and request form do not show at least three identical patient identifiers 2.The sample is in the incorrect collection media 3.The request form is not sufficiently completed 4.The sample is not of sufficient volume 5.The sample is too old